July 3, 2024
BRI’s Innovation Fund Sparks New Discoveries
Learn about one of the first projects launched with this funding, where Eddie James, PhD, and Caroline Stephanie, PhD, are exploring a new approach to treat type 1 diabetes.
May 30, 2024
Passing on the Hope: What I Learned Running Two Half-Marathons on Two Coasts in Two Days
Gretchen reflects on her journey from Washington, D.C., to Portland, Oregon, as she ran back-to-back half-marathons to raise autoimmune disease awareness and support immune system disease research at BRI.
April 3, 2024
Two Teens, Two Clinical Trials, One Vision: Living Better With T1D
Hear from teenagers Clara and Gibson about their experience participating in research and why it's important to them.
April 2, 2024
Why a New Cancer Treatment Can Lead to Autoimmunity
Why do some people taking checkpoint inhibitors for cancer develop side effects that look like autoimmunity? And could these side effects actually be a sign that the treatment is working? Peter Linsley, PhD and Ty Bottorff, PhD, intend to find out.
April 1, 2024
New Frontiers in Immunology: Studying Diseases in the Tissues Where They Happen
Learn how Eddie James, PhD, Peter Morawski, PhD, and other BRI scientists are exploring tissue-specific immunology and why this approach is fueling discoveries.
March 12, 2024
2 Halfs, 2 Coasts, 2 Days: Gretchen Schoenstein Takes on Challenge for BRI and Everyone with Autoimmune Diseases
Longtime BRI supporter Gretchen Schoenstein is taking on a bold new challenge: 2 half-marathons, in 2 days, on 2 coasts.
January 12, 2024
New Grant Fuels Research Into Preventing Autoimmunity
Naive T cells are like the rookies of your immune system. They’re young and inexperienced. They grow up to do different jobs, most of which help protect your body from viruses and bacteria. But a few stray down the wrong path — growing up to become cells that cause autoimmune disease.
January 11, 2024
John Ray, PhD, Receives NIH New Innovator Award
The prestigious NIH Director’s New Innovator Award provides significant funding for innovative research that holds the promise of high rewards. And BRI geneticist John Ray, PhD, just received one.
January 11, 2024
Ready for This Moment: Exploring Prevention of Ulcerative Colitis
Adam Lacy-Hulbert, PhD, was reading through the latest scientific papers when one finding stopped him in his tracks: Groups from Kyoto University and Mount Sinai described an autoantibody specific to people with ulcerative colitis (UC).
January 10, 2024
On the Brink of a Golden Age of Medicine
"I know we will reach that golden age, and BRI’s research in human immunology is the vehi¬cle that will take us there. This field has shepherded incredible advances in recent years, including new vaccines, new cancer treatments, and new and better treatment options for autoimmune disease."
